Plant-Derived <i>Lactobacillus paracasei</i> IJH-SONE68 Improves Chronic Allergy Status: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
We have recently demonstrated that the exopolysaccharides (EPSs) produced by a plant-derived lactic acid bacterium, <i>Lactobacillus paracasei</i> IJH-SONE68, prevent and ameliorate allergic reaction on contact in dermatitis model mice. In the present study, we conducted a clinical trial...
Guardado en:
Autores principales: | Masafumi Noda, Keishi Kanno, Narandalai Danshiitsoodol, Fumiko Higashikawa, Masanori Sugiyama |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e957094058d44a9b3ce22edc065e865 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis
por: Masafumi Noda, et al.
Publicado: (2021) -
<i>Lacticaseibacillus paracasei</i>: Occurrence in the Human Gut Microbiota and <i>K</i>-Mer-Based Assessment of Intraspecies Diversity
por: Maria Frolova, et al.
Publicado: (2021) -
Biosynthesis of exopolysaccharide and structural characterization by Lacticaseibacillus paracasei ZY-1 isolated from Tibetan kefir
por: Luyao Xiao, et al.
Publicado: (2021) -
Assessment of the feed additive consisting of Lacticaseibacillus paracasei (formerly Lactobacillus paracasei) DSM 16245 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG)
por: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Publicado: (2021) -
A randomized, double blind, parallel, placebo‐controlled study to investigate the efficacy of Lactobacillus paracasei N1115 in gut development of young children
por: Shijie Wang, et al.
Publicado: (2021)